Description
Dorucin -10 mg
Composition – Each vial contains Doxorubicin Hydrochloride 10 mg
Therapeutic Class – Chemotherapeutic drug
Dorucin – Multi-Cancer Targets
Aprazer’s Dorucin is a widely accepted and globally prescribed anticancer medicine to treat various types of cancer, including blood and lung.
Aprazer Healthcare: Global Exporter and Manufacturer of Oncology Medicine
Aprazer Healthcare, committed to global health equity, manufactures affordable, premium-quality anticancer therapeutics.
- • WHO-GMP certified.
- • Assured safety and therapeutic efficacy.
- • Global reach – exporting to 20+ countries.
What is Dorucin?
Dorucin is a cytotoxic anticancer medicine that is widely used to kill various types of cancer cells.
Uses of Dorucin-
- • Leukemia
- • Breast cancer
- • Small cell lung cancer
- • Bladder cancer
- • Lymphoma
- • Myeloma
- • Sarcomas
- • Thyroid
- • Gastric cancers
How does Dorucin work?
- • It cuts down DNA strands, inhibits topoisomerase 2.
- • It also produces free radicals to oxidize harmful cancer cells.
Side effects of Dorucin
- • GIT upset – Nausea, vomiting
- • Mouth and throat ulcers
- • Hair loss
- • Urine discoloration
- • Red eyes
- • Vesicant effect
Toxicities
Dose-dependent toxicities –
- • Cardiac toxicity
- • Myelosuppression
- • Hepatotoxicity
- • Risk of irreversible cardiomyopathy.
Contraindications
- • Not to be used in patients with prior hypersensitivity to the drug or its excipients.
- • Breastfeeding mothers
- • Pregnant women
Precautions
To be used cautiously in patients with
- • Cardiac disease
- • Low blood count
- • Liver disease
Warnings
To be used under medical supervision as a slow intravenous infusion over 15-60 minutes.
Important Safety and Monitoring Considerations
Regular monitoring of the liver function, cardiac function, and regular blood count is required.
Storage:
Store at 2-8 degrees Celsius (refrigerator), protected from light.
Reconstituted solution to be used immediately.
